{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    9,
    13,
    14,
    81
  ],
  "modelUsed": "gemini-3-flash-preview",
  "advanced": {
    "studyAmendments": [
      {
        "id": "amend_1",
        "number": "1.0",
        "name": "Amendment 1.0",
        "scope": {
          "id": "7ce7d90b-5623-4c88-af89-a0849dfdfe2f",
          "code": "Global",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Global",
          "instanceType": "Code"
        },
        "primaryReason": {
          "id": "d71839ef-903b-45d9-bfdb-59577a7e061e",
          "code": {
            "id": "ffdb7468-261e-4bbe-a5be-e58b875c6e28",
            "code": "C98782",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Protocol Amendment",
            "instanceType": "Code"
          },
          "otherReason": "Protocol Amendment",
          "instanceType": "StudyAmendmentReason"
        },
        "geographicScopes": [
          {
            "id": "17cb7e3f-d4ed-4ba7-8299-d18bae080c16",
            "type": {
              "id": "2433bca2-b2e0-4e3a-90e3-27a0f1a7fb7c",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "instanceType": "GeographicScope"
          }
        ],
        "instanceType": "StudyAmendment",
        "summary": "Initial creation of the clinical study protocol.",
        "effectiveDate": "2016-10-26",
        "reasonIds": [
          "ar_1_1"
        ],
        "newVersion": "1.0"
      },
      {
        "id": "amend_2",
        "number": "2.0",
        "name": "Amendment 2.0",
        "scope": {
          "id": "f6a55321-dc37-42c3-a3c0-7996bca3efca",
          "code": "Global",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Global",
          "instanceType": "Code"
        },
        "primaryReason": {
          "id": "8165fff4-024e-4776-90c0-795bbf2ada4a",
          "code": {
            "id": "6fe74e5b-b7c3-45e1-bbf3-b109da2a03ae",
            "code": "C98782",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Protocol Amendment",
            "instanceType": "Code"
          },
          "otherReason": "Protocol Amendment",
          "instanceType": "StudyAmendmentReason"
        },
        "geographicScopes": [
          {
            "id": "f1a36710-b383-443c-95ac-ec49cad7edd2",
            "type": {
              "id": "207eea62-8c60-440b-b8bc-36def11f9d1c",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "instanceType": "GeographicScope"
          }
        ],
        "instanceType": "StudyAmendment",
        "summary": "The main reasons for preparation of this amendment were to expand the adverse event of interest category for amputations based on regulatory discussion, incorporate an Echocardiographic Sub-study, update secondary objectives regarding KCCQ scoring, and refine safety reporting procedures to simplify SAE reporting and minimize risks of withholding renal AEs. It also clarified exclusion criteria, contraceptive requirements, and guidelines for essential treatment during acute worsening of heart failure.",
        "effectiveDate": "2017-10-25",
        "reasonIds": [
          "ar_2_1",
          "ar_2_2",
          "ar_2_3",
          "ar_2_4"
        ],
        "previousVersion": "1.0",
        "newVersion": "2.0"
      }
    ],
    "amendmentReasons": [
      {
        "id": "ar_1_1",
        "code": "ADMINISTRATIVE",
        "description": "Administrative",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_2_1",
        "code": "REGULATORY",
        "description": "Regulatory",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_2_2",
        "code": "SAFETY",
        "description": "Safety",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_2_3",
        "code": "SCIENTIFIC",
        "description": "Scientific",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_2_4",
        "code": "OPERATIONAL",
        "description": "Operational",
        "instanceType": "AmendmentReason"
      }
    ],
    "countries": [
      {
        "id": "country_1",
        "name": "United Kingdom",
        "instanceType": "Country",
        "code": "GB"
      },
      {
        "id": "country_2",
        "name": "Sweden",
        "instanceType": "Country",
        "code": "SE"
      }
    ],
    "studySites": [
      {
        "id": "site_1",
        "name": "Site 1",
        "instanceType": "StudySite",
        "countryId": "country_1",
        "city": "Glasgow"
      }
    ],
    "summary": {
      "amendmentCount": 2,
      "countryCount": 2,
      "siteCount": 1
    },
    "geographicScope": {
      "id": "geo_1",
      "name": "Study Geographic Scope",
      "scopeType": "International",
      "instanceType": "GeographicScope",
      "countryIds": [
        "country_1",
        "country_2"
      ]
    }
  },
  "rawResponse": {
    "amendments": [
      {
        "number": "1.0",
        "effectiveDate": "2016-10-26",
        "summary": "Initial creation of the clinical study protocol.",
        "previousVersion": null,
        "newVersion": "1.0",
        "reasons": [
          "Administrative"
        ]
      },
      {
        "number": "2.0",
        "effectiveDate": "2017-10-25",
        "summary": "The main reasons for preparation of this amendment were to expand the adverse event of interest category for amputations based on regulatory discussion, incorporate an Echocardiographic Sub-study, update secondary objectives regarding KCCQ scoring, and refine safety reporting procedures to simplify SAE reporting and minimize risks of withholding renal AEs. It also clarified exclusion criteria, contraceptive requirements, and guidelines for essential treatment during acute worsening of heart failure.",
        "previousVersion": "1.0",
        "newVersion": "2.0",
        "reasons": [
          "Regulatory",
          "Safety",
          "Scientific",
          "Operational"
        ]
      }
    ],
    "geographicScope": {
      "type": "International",
      "countries": [
        {
          "name": "United Kingdom",
          "code": "GB"
        },
        {
          "name": "Sweden",
          "code": "SE"
        }
      ],
      "regions": [],
      "plannedSites": 600
    },
    "sites": [
      {
        "siteName": "University of Glasgow / BHF Cardiovascular Research Centre",
        "city": "Glasgow",
        "country": "United Kingdom"
      }
    ]
  }
}